Live feed08:28:29·12mANALYSTRatingvia QuantisnowLeerink Partners resumed coverage on Zentalis Pharma with a new price targetByQuantisnow·Wall Street's wire, on your screen.ZNTL· Zentalis Pharmaceuticals Inc.Health CareOriginal source